Market cap
$153.3m
End-of-day close multiplied by current shares on issue.
MLN · NZX
Marlin Global is an NZX-listed investment companies / listed investment company company. Its latest covered result is FY26, with FY21 - FY26 of source-backed result history on Annolyse.
Latest result
FY26, released 25 August 2026
| Metric | Value | Change |
|---|---|---|
| Revenue | -$12.7m | — |
| NPAT | -$17.3m | n/m |
| DPS | 1.6c | — |
Source: latest published briefing (FY26, released 25 August 2026). Change compares against the prior equivalent period: FY25, released 18 August 2025.
Valuation
Trailing P/E, EV/EBITDA, price-to-book and price-to-free-cash-flow ratios combine the latest available close with filing data. They are comparative measures, not forecasts or recommendations.
The latest close and share count context for the market price.
Market cap
$153.3m
End-of-day close multiplied by current shares on issue.
Yield and investment-company valuation where supported.
Dividend yield
10.7%
Trailing dividends compared with the latest close.
Premium / discount
-16.9%
For investment companies, price compared with reported NTA.
Total return
Not available
Available once dividend and adjustment data are verified.
How the market price compares with recent earnings and cash-flow inputs.
P/E
Not available
Not meaningful when recent earnings are negative.
EPS
-0.08
Recent filing-derived earnings per share.
PEG
Not available
Not available for this company right now.
EV/EBITDA
Not available
Not meaningful for this company type.
P/FCF
Not available
Not available for this company right now.
Daily closes use the full available width, with hover and touch values for each observation. Expand the chart to see more detail.
Five years of daily closes, as at close, 5 June 2026. Weekends, suspensions, and listing gaps stay as natural gaps in the time scale.
Filing-period markers only: EOD close on or before each release date divided by filing-derived trailing NPAT where both inputs verify. Periods with P/E at or above 100x are shown as gaps because earnings yield below 1% makes the multiple denominator-driven, not meaningful. Suppressed periods: FY25.
Chat
Ask follow-up questions about Marlin Global's latest result and company history.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Financial history
The latest period is shown first.
| Metric | FY2612 MONTHS25 August 2026 | HY266 MONTHS16 February 2026 | FY2512 MONTHS18 August 2025 | HY256 MONTHS21 February 2025 | FY2412 MONTHS19 August 2024 | HY246 MONTHS22 February 2024 | FY2312 MONTHS22 August 2023 | HY236 MONTHS17 February 2023 | FY2212 MONTHS22 August 2022 | HY226 MONTHS28 February 2022 | FY2112 MONTHS24 August 2021 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -$12.7m | $9.4m | — | $11.3m | $1.2m | $12.4m | $0.76m | -$9.4m | $0.66m | $6.3m | $78.1m | Chart |
| Revenue growth % | n/m | -17.2% | — | -8.6% | 56.7% | 231.4% | 15.8% | -250.3% | -99.2% | -80.6% | — | Chart |
| EBITDA | — | — | — | — | — | — | — | -$10.6m | -$61.2m | $4.2m | $71.5m | Chart |
| EBITDA margin % | — | — | — | — | — | — | — | 112.8% | n/m | 66.7% | 91.6% | Chart |
| PBT | — | $7.5m | $2.5m | $9.3m | $38.4m | $10.6m | $24.4m | -$10.6m | -$61.2m | $4.2m | $71.5m | Chart |
| PBT growth % | — | -19.4% | -93.5% | -12.3% | 57.4% | — | — | — | — | -85.4% | 216.4% | Chart |
| NPAT | -$17.3m | $6.5m | $0.3m | $8.1m | $37.2m | $10.2m | $23.6m | -$11.6m | -$60.4m | $3.6m | $69.2m | Chart |
| NPAT growth % | — | -19.8% | -99.2% | -20.6% | 57.6% | — | — | — | — | -86.0% | 206.2% | Chart |
| Operating cash flow | — | $7.2m | $7.2m | $8.4m | -$2m | -$11.4m | $22.6m | $7.5m | $3.4m | $5.3m | -$16.6m | Chart |
| OCF / EBITDA % | — | — | — | — | — | — | — | -70.9% | -5.5% | 126.4% | -23.2% | Chart |
| DPS | 1.6c | 1.9c | — | 2.0c | 2.1c | 1.9c | 1.8c | 1.7c | 1.9c | 2.5c | 2.5c | Chart |
| Payout ratio vs NPAT % | — | 65.3% | — | 55.1% | 22.3% | 38.1%Outside range low payout ratio versus npat. 38.1%; 3-period range 55.1% to 132.5%. Payout ratio versus NPAT: 38.1%, below normal range; 3-period mean 84.3%, range 55.1%-132.5%. | 29.9% | — | — | 132.4%Outside range high payout ratio versus npat. 132.5%; 3-period range 38.1% to 65.3%. Payout ratio versus NPAT: 132.5%, above normal range; 3-period mean 52.8%, range 38.1%-65.3%. | 22.4% | Chart
|
| Annual payout ratio vs EPS % | — | — | — | — | 22.3% | — | 29.9% | — | — | — | 22.4% | Chart |
| ROE % | — | 3.0% | 0.2% | 3.6% | 16.7% | 5.1%Outside range high roe. 5.1%; 3-period range -7.2% to 3.6%. ROE: 5.1%, above normal range; 3-period mean -0.7%, range -7.1%-3.6%. | 12.2% | -7.2% | -33.9%Unprecedented low roe. -33.9%; 4-period range 0.2% to 28.3%. ROE: -33.9%, unprecedented low; 4-period mean 14.3%, range 0.2%-28.3%. | 1.5% | 28.3%Outside range high roe. 28.3%; 4-period range -33.9% to 16.7%. ROE: 28.3%, above normal range; 4-period mean -1.2%, range -33.9%-16.7%. | Chart
|
| Net debt | — | — | -$3.2m | — | — | — | — | — | — | — | — | — |
| Debtor days | — | — | — | — | 2 | 4 | 4 | n/m | 4 | 10 | n/m | Chart |
| Total assets | — | $214.9m | $214.9m | $230.9m | $225.4m | $202.2m | $202.4m | $163m | $180.3m | $243.2m | $252.1m | Chart |
Reference: annolyse.ai/companies/mln
Note: Figures are shown as reported. Half-year and full-year absolute values are not directly comparable. Growth rates and ratios are the meaningful comparison across mixed periods.
Net tangible asset or net asset value per share, shown in per-share cents for chart readability.
Recurring investment-income or revenue-return proxy, excluding fair-value movement where disclosed.
Total income or return including fair-value or capital movement where disclosed.
Net asset base attributable to shareholders or unitholders.
Recurring investment income or revenue-return coverage of cash distributions where source-backed.
Portfolio or NAV total return compared with the disclosed benchmark or index return.
The setup & the reality
The latest result is checked against what the prior briefing said to watch.
Historical setup
Previous analysisHY26Result releasedAnnolyse analysis published
From Marlin's portfolio returned 3.0% against an unprecedented 14.0% benchmark
No forward target or shape guidance is supplied in this release, so the result must be judged against context rather than a stated plan. The relevant context is that benchmark strength of this magnitude is outside Marlin's four-year experience, which means the 11.0pp underperformance partly reflects an exceptional comparator rather than a step-change in manager skill, but it does not explain why the portfolio captured so little of the upside.
The next read points are whether portfolio return narrows the gap if benchmark conditions normalise, and whether distribution per share holds if income coverage stays below 10%. Neither is addressable from this release.
Open questions
This briefing cannot assess the underlying portfolio holdings, sector positioning, or manager attribution detail that would explain the benchmark gap.
Primary issuer documents used for the FY26 briefing. Document labels are preserved from the publication record; Annolyse does not relabel every financial report as an annual report.
MLN - Commentary for the year ended 30 June 2026
FY26 / results releaseMLN - Financial statements for the year ended 30 June 2026
FY26 / financial reportMLN - Preliminary year end announcement - 30 June 2026
FY26 / results announcementMarlin Global 2025 Annual Report
FY25 / financial reportMLN - Commentary for interim period to 31 December 2025
HY26 / results releaseMLN - Financial statements for the interim period 31 Dec 2025 incl review report
HY26 / financial reportMLN - Preliminary half year announcement - 31 December 2025
HY26 / results announcementMarlin ASM Presentation 7 November 2025
HY26 / commentaryPeer context
These companies share the same curated sub-sector label. Their reporting definitions can still differ, so compare the underlying measures before ranking them.
Archive
The full chronological archive contains every published result briefing.
FY26 · Released 25 August 2026
A $17.3m net loss and an NTA of $0.80 reflect portfolio returns that trailed the benchmark by 39 percentage points, not weaker income.
HY26 · Released 16 February 2026
Manager underperformance widened to 11.0pp and NAV per share fell 8.3% even as the absolute portfolio result stayed within historical norms.
FY25 · Released 18 August 2025
Investment income held above the historical baseline at $1.2m, but portfolio total return fell 86.3% while the benchmark posted a record 50% gain.
HY25 · Released 21 February 2025
NTA per share rose 8.5% to $1.02 and dividend income hit an unprecedented $0.9m, but benchmark underperformance is the central read.
FY24 · Released 19 August 2024
Strong absolute gains came against a benchmark return of 15.2%, which sits at the lower edge of Annolyse's historical range.
HY24 · Released 22 February 2024
An above-range portfolio result drove the swing to profit, but running investment income of NZ$0.4m covers only 7.9% of distributions paid.
Get the next Marlin Global result briefing and five-year history updates by email.